Microsoft word - 14-dr_soltan_dallal_rtl86_12-5.doc
Iranian J Publ Health, Vol. 37, No.1, 2008, pp.103-107 Iranian J Publ . Health, Vol , N 37 o. , 1 . , pp 2008 10 - 3 107 Original Article High Level Resistance of Enterococcus faecium and E. faecalis Isolates from Municipal Sewage Treatment Plants to Gentamicin M Saifi 1,2, *MM Soltan Dallal 1, MR Pourshafie 2, MR Eshraghian 3, MR Pourmand 1, MH Salari 1, MH Shirazi 1 1Dept. of Bacteriology, School of Public Health, Medical Sciences/University of Tehran, Iran 2 Dept. of Microbiology, Pasteur Institute of Iran, Tehran 3 Dept. of Biostatistics, School of Public Health, Medical Sciences/University of Tehran, Iran (Received 13 Jun 2007; accepted 17 Dec 2007)
Abstract Background: Enterococci are members of the normal gut flora and released into the environment via sewage outlets, where they can survive for long times. Infections with high-level gentamicin resistant (HLGR) enterococci are emerg- ing worldwide. HLGR enterococci have developed a resistance to most antibiotics commonly used for enterococcal in- fections therefore; treatment of infections caused by HLGR enterococci is difficult. The present study investigated the distribution and antibiotic resistance of HLGR Enterococcus faecium and E. faecalis isolates from raw wastewater sam- ples in Tehran. Methods: Raw wastewater samples were collected during the period from November 2006 to May 2007 at 3 sewage treatment plants located in different parts of Tehran. All 90 HLGR enterococcal isolates were identified to the species level by biochemical and PCR assays and subjected to antibiotic susceptibility testing. Results: Sixty four percent (58 of 90) of isolates were E. faecium and 29%(26 of 90) of them were E. faecalis.The highest level of antibiotic resistance was observed with erythromycin (63%), co-trimoxazole (69%) and tetracycline (92%) for E.faecalis and with erythromycin (97%), ciprofloxacin (47%), co-trimoxazole (45.5%) and tetracycline (47%) for E. faecium. Multiresistance against 3 to 4 antimicrobial was present in 27.5% and 15.5% of the isolates, re- spectively. Conclusion: HLGR E. faecium were more commonly found than E. faecalis. Species identification of HLGR entero- cocci enables us to assess species-specific antibiotic susceptibility patterns in our area. The present study reviled that HLGR E. faecalis remained more susceptible than E. faecium against the usual first-line and alternative treatments. Keywords:E. faecalis, Enterococci, gentamicin resistance, Iran Introduction
The prevalence, severity and antibiotic resistance
Enterococci are normal inhabitants of the intes-
of and the mortality rate from enterococcal in-
tinal floras of human and warm-blooded ani-
fections are often species dependent (5).
mals. They are released into the environment
The emergence of high-level gentamicin resis-
through feces (1). Enterococci have the ability
tance (HLGR) is of serious worldwide due to
to survive adverse environmental conditions (2).
their multi-resistant (6). According to a study (7),
The enterococci may be superior indicator or-
52% of enterococcal clinical isolates in Tehran
ganisms than fecal coliforms as a water qual-
ity indicator (1). They have emerged as impor-
Nevertheless, based on data in the literatures,
tant human pathogens that are responsible for
90-99% of multiple resistant E. faecium and
nosocomial infections and with the emergence of
E. faecalis found in sewage actually stem from
aminoglycoside and glycopeptides resistance (3).
the human population and several cycles of con-
Of 14 or more, exist enterococcal species, only
tinuation and recontamination with them ap-
E. faecalis and E. faecium commonly colo-
pears to exist between animals, humans and
nize and infect humans in detectable numbers
(3). They can cause urinary tract and wound in-
This sampling was aimed at obtaining informa-
fections, septicemia and endocarditis (4).
tion on prevalence of two most clinically impor-
*Corresponding author: Tel: +98 21 66465404, E-mail: [email protected], pp M Saifi et al: High Level Resistance of . ,
tant species E. faecalis and E. faecium HLGR
heim, Germany), 2.5 pM of each primers, 2.5
enterococci in sewage treatment plants in Tehran,
µl of 10X PCR buffer, 1.5 mM MgCl2 and DNA
template 5 µl. DNA amplification was carried
out with the following thermal cycling profile.
Materials and Methods
Initial denaturation at 94 ºC for 5 min, 30 cy-cles of amplification (denaturation at 94 ºC for
Sample collection: Inflow raw wastewater sam-
1 min ,annealing at 54 ºC for 1 min and ex-
ples were collected from three sewage treat-
tension at 72 ºC for 1 min ), followed by a fi-
ment plants located in the different parts of Te-
hran during the period from November 2006
Antimicrobial susceptibility testing: The suscep-
to May 2007. Five hundred milliliter of each
tibility to antibiotics was tested by the agar disk
sample was collected in a sterile container trans-
diffusion method according to CLSI guidelines
ported to the laboratory and analyzed within a
(13). The antimicrobial disks were used as fol-
lows: vancomycin (30µg), ciprofloxacin (5µg),
Isolation of HLGR enterococci: Samples were
ampicillin (10µg), high content gentamicin (120
subjected to serial 10-fold dilutions with normal
µg), trimethoprim/sulfametoxazole (1.25: 22.75),
saline, before filtration. The membrane filters
tetracycline (30µg), erythromycin (30µg) and
were put on brain heart infusion agar (Becton
nitrofurantoin (300µg) were purchased from BBL
Dickinson and Co., Sparks, MD, USA) plates
and preincubated for 2 h at 37 ºC (9). The mem-
dalfopristin (15 µg) and linezolid (30 µg) from
branes were transferred to m-Enterococcus
Mast Diagnostics Ltd. (Bootle, Mersey Side,
agar (Becton Dickinson and Co., Sparks, MD,
UK) and teicoplanin (30 µg) from BR (BioRad,
USA) supplemented with 64 mg of gentamicin
Hercules, CA, USA). Isolates with intermediate
per liter. Agar plates were incubated for 48 h
levels of susceptibility were classified as resistant.
at 37 ºC. Distinct colony growth was transferred to blood agar plates for following investigations.
Biochemical identification of species: All of the
enterococcal isolates were tested for phenotypic
Ninety HLGR enterococcal isolates were re-
characteristics by conventional methods, based
covered from three sewage treatment plant
on the following criteria: growth on Bile Es-
samples. Among HLGR isolates, the follow-
culin agar and in 6.5% NaCl broth, absence of
ing species were identified; 58 isolates of E.
catalase and presence of pyrolidonyl arylami-
faecium (64%), 26 isolates of E. faecalis
dase (PYR test). Species- level identification
(29%) and six (7%) other enterococcal spe-
was performed by biochemical tests including
cies. Amplification of genus, E. faecals- spe-
acid fermentation of manitol, sorbitol, sucrose,
cific and E. faecium- specific targets produced
arabinose and raffinose, motility and arginine
320 bp, 941 bp and 658 bp bands, respectively
(Fig. 1). Species distribution by PCR method
Detection of genus and species by PCR. All
was the same as detected by biochemical tests.
strains were confirmed for genus and species
Data obtained from antimicrobial susceptibility
by PCR with three different primer sets. Am-
testing summarized in Table 2. Among 58 E.
plification of both speciesspecific, and genus
faecium and 26 E. faecalis isolates with HLGR
(rrs) targets produced bands corresponding to
phenotype, resistance percents to erythromicin,
their respective molecular size (Table 1). For
ciprofloxacin, co-trimoxazole, tetracycline, am-
DNA extraction, one isolated colony was sus-
picillin, nitrofurantoin and synercid were 97%
pended in 200 µl distilled water and boiled at
versus 63%, 47% versus 19%, 45.5% versus
100 ºC for 10 min (11). After centrifugation,
69%, 47% versus 92%, 18% versus 7.5%, 17%
10 µl of supernatant was used as the DNA
versus 0% and 3.5% versus 100%, respectively.
template. PCR reaction were performed in a
Simultaneously resistance to ampicillin, ciproflox-
total volume of 25 µl containing 0.8 mM dNTP,
acin, tetracycline and co-trimoxazole were 15.5%
which was more detected in E. faecium.
Iranian J Publ Health, Vol. 37, No.1, 2008, pp.103-107
Only 19% of E. faecalis isolates were resistant to
comycin, teicoplanin and linezolid was detected
ciprofloxacin, which differs markedly from 47%
obtained by E. faecium. No resistance to van-
Table 1: Nucleotides sequences of primer sets Type of primers Sequence(5´-3´) Reference Product size(bp) Table 2: Antibiotic resistance among HLGR strains isolated from sewage treatment plants in Tehran. The
abbreviations are; V: vancomycin, Te: tetracycline, Am: ampicillin, E: erythromycin, Cip: ciprofloxacin, Tei:
teicoplanin, Fm: nitrofurantoin, Syn: quinupristin-dalfopristin (Synercid), Lin:linezolid, SXT: co-trimoxazole.
Number of Number (%) of HLGR isolates resistant to: isolates V Te Am E Cip Tei Fm Syn
26(29) (0) 23(92) 2(7.5) 16(63) 5(19) (0)
58(64) (0) 27(47) 10(18) 56(97) 27(47) (0) 10(17) 2(3.5) (0) 25(43)
Fig. 1: A: PCR for Enterococcus faecium, B: PCR for Enterococcus faecalis, C: PCR for Genus of Enterococci Discussion
with nosocomial infections (14). HLGR in E.
In the present study HLGR enterococci were
faecalis is now a very common feature world-
found in sewage along with high resistance to
wide and the reported prevalence exceeds 50%
other antimicrobial agents especially among E.
of the E. faecalis strains isolated in some hos-
faecium isolates. HLGR multiresistant entero-
pitals (6). According to an area specific sur-
cocci have been identified as a major issue of
vey in Tehran the prevalence of HLGR E. fae-
concern, as they have been found associated
calis isolates reported 30% with high degree
pp M Saifi et al: High Level Resistance of . ,
of multiresistance (15). This finding was alarm-
resistant isolates was found. Co-resistance to four
ing as infection due to HLGR isolates are dif-
and five antibiotic simultaneously was reported
Finding HLGR E. faecalis in sewage, which
Similar results were obtained in other study,
is much more common in human enterococcal
which showed distribution of enterococci in
infections, suggest a potential high risk for com-
sewage (18). Out of 45 enterococcal isolates
munity- acquired HLGR as well as the pos-
from municipal wastewater, 32 isolates were
sibility of transferring antibiotic resistance genes
E. faeclais, 10 isolates belonged to E. faecium
Resistance to multiple classes of antibiotics is
According to de Costa’s report, among 983
common in enterococci as was seen in this
enterococci, multidrug resistant isolates were
study. We found that, resistance patterns dif-
present in 49.4% of the isolates. Only 3.3%
fered between species. Overall, E. faecium had
and 0.6% of the investigated strains were re-
a higher prevalence of resistance among the
sistant to ampicillin and vancomycin. Resis-
panel antibiotics, while E. faecalis isolates had a
tance rates to tetracycline, erythromycin, nitrofu-
relatively lower resistance to ampicillin, eryth-
rantoin and ciprofloxacin were 34.6%, 24.8%,
romycin and ciprofloxacin excluding their in-
herent resistance to quinupristin/dalfopristin (syn-
Ferreira in 2006 in Portugal studied the antibi-
ercid). Resistance rate against synercid among
otic resistance of enterococci and related bac-
HLGR E. faecium isolates was 3.5%. Synercid
teria in an urban wastewater treatment plant
has a spectrum of activity against multi-resis-
and demonstrated that the predominant species
tant enterococci excluding E. faecalis and is
were E. haire,E. faecium and E. faecalis. The
available for the treatment of multiresistant E.
percents of resistance observed to erythromy-
cin, ciprofloxacin and tetracycline ranged be-
E. faecalis resistance to ampicillin and vanco-
tween 23% and 57%. Only two E. faecium of
mycin is uncommon (17).However, in this study
27 enterococcal isolates were HLGR (20).
E. faecalis resistance to ampicillin was found
All the HLGR E. faecium isolates in our study
in low degree (7.5%) and no resistance to van-
were sensitive to linezolid, which was recently
launched for the treatment of Gram-positive
The resistance rate to co-trmoxazole and tetra-
cycline among E. feacalis was more than E.
Conclusively, our data indicate that the relax
faecium.This may be because of widely usage
usage of antimicrobials had created a large pool
of these two antimicrobials in human and animal
of resistance genes which may be disseminate
infections and selective antibiotic pressure or sim-
resistant bacteria into the environment and could
ply transfer of resistance genes or combination
potentially pose a health treat to human in the
A high percentage of the E. faecium isolates
were resistant to multiple drugs, contributes to
Acknowledgements
the challenge of selecting therapeutic measures.
This study was supported by the Deputy of Re-
Distribution of enterococcal isolates was com-
search, Medical Science/University of Tehran.
parable to other studies. For example Cupakova
The authors declare that they have no Conflict
in Czech Republic during one year (2003) re-
covered 100 enterococcal isolates from differ-
ent wastewater samples including 60 isolates
References
as E. faecalis, 8 strains were allotted to E. fae-cium and the rest were of other species. The
(2000). Classification of antibiotic resis-
susceptibility to antibiotics showed that the ma-
jority of isolates (95%) was resistant to more
discriminate analysis: use in predicting
than one antibiotic tested and no vancomycin
the source of fecal contamination in sub-
Iranian J Publ Health, Vol. 37, No.1, 2008, pp.103-107
tropical waters. Appl Environ Microbiol,
9. Kuhn I, Iversen A, Mollby R (2003). The
versity of enterococcal populations from
the food chain and the environment. Int J Food Microbiol, 2088(2-3):189-96.
10. Facklam R.R, Collins MD (1989) Identifi-
enterococci. Lancet, 348(9042):1615-19.
tional test scheme. J Clin Microbiol,
Multiple-drug resistant enterococci: the
11. Rahimi F, Talebi M, Saifi M, Pourshafie
for the future. Emerg Infect Dis, 4(2):
cin resistance genes by multiplex PCR in
Tehran sewage. Iran Biomed J, 11(3):
12. Kariyama R, Mitsuhata R, Chew JW, Cle-
comycin in Enterococcus faecalis and
Enterococcus faecium isolates from clini-
reliable multiplex PCR assay for surveil-
lance isolates of vancomycin-resistant en-
als in five Nordic hospitals. J Antim-
terococci. J Cli Microbiol, 38(8):3092-95.
13. National Committee for clinical Laboratory
for Antimicrobial Susceptibility tests ap-
assay for identification of Enterococcus faecium. J Cin Microbiol, 35(5):1248-
6. Woodford N, Reynolds R, Turton J, Scott
14. Papaparaskevas J, Vatopoulos A, Tassios
of Enterococcus faecalis highly resis-
aminoglycoside-resistant enterococci. J
tant to gentamicin and ciprofloxacin from
bacteraemias in the UK and Ireland. J
15. Feizabadi MM, Aliahmadi A, Mobasheri
7. Feizabadi MM, Maleknejad P, Asgharzadeh
teristics and population genetics of En-terococcus faecalis cultured from pa-
tients in Tehran during 2000-2001. Can
lates of Enterococcus faecalis and En-terococcus faecium in Iran. Microb
16. Arias CA, Reyes J, Zuniga M, Cortes L,
surveillance of antimicrobial resistance in
lombian hospitals, 2001-2002. J Antim-
ministration of antimicrobials to slaugh-
17. Cetinkaya, Y, Falk P, Mayhali G (2000).
Vancomycin resistant enterococci. Clin pp M Saifi et al: High Level Resistance of . ,
18. Cupakova S, Lukasova J (2003). Agricultural
age water treatment plants Water Res,
and municipal waste water as a source of
antibiotic-resistant enterococci. Acta Vet
20. Ferreira da Silva M, Tiago I, Verissimo A,
19. Martins da Costa P, Vaz-Pires P,Bernardo
F (2006). Antimicrobial resistance in En-
FEMS Microbiol Ecol, 55(2):322-29.
NOTE: NURSE MUST INITIAL EACH INDIVIDUAL ORDER (All orders to be deleted are to be crossed out with a single line and initialed by the physician) 1. Finger sticks blood glucose monitoring. 2. For Blood Glucose (BG) less or equal to 60 or symptoms of hypoglycemia, follow “ Hypoglycemia Protocol Order Set” on page 2 3. Scheduled Insulin Therapy subcutaneously as shown below
Peninsula-Delaware Conference of the United Methodist Church 1 Day Service Project 2014 MEDICAL RECORD AND LIABILITY RELEASE FORM (Each person must bring this form with them in order to register. Persons without a form will not be able to attend.) Date of conference: April 5, 2014 Church: _________________________________________ Date signed: _______________ SECTION 1: MEDICAL